Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Selmer

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Diabetes and Its Complications|April 1, 1995
Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?E Boel, J Selmer, H J Flodgaard, et al.
Clinical Chemistry|August 1, 1990
Analytical evaluation of a sensitive enzyme immunoassay for determinations of creatine kinase isoenzyme MBP J Jørgensen, M Hørder, J Selmer, et al.
European Journal of Biochemistry|July 15, 1988
Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2S Thorsen, M Philips, J Selmer, et al.
Thrombosis and Haemostasis|October 28, 1987
Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasmaM Jørgensen, M Philips, S Thorsen, et al.
European Journal of Nuclear Medicine|January 1, 1991
Detection of deep venous thrombosis with indium 111-labelled monoclonal antibody against tissue plasminogen activatorN Tromholt, B Hesse, O Folkenborg, et al.
Journal of Immunoassay|January 1, 1988
Monoclonal antibodies against human angiotensinogen, their characterization and use in an angiotensinogen enzyme linked immunosorbent assayI Rubin, S Lykkegaard, A A Olsen, et al.
Thrombosis and Haemostasis|November 10, 1992
A specific immunologic assay for functional plasminogen activator inhibitor 1 in plasma--standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic diseaseM Philips, A G Juul, J Selmer, et al.
Thrombosis and Haemostasis|April 30, 1986
Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placentaM Philips, A G Juul, S Thorsen, et al.
Thrombosis and Haemostasis|April 7, 1987
A sensitive solid-phase immunosorbent assay for tissue-type plasminogen activator activity in plasma using trinitrobenzoylated poly-D-lysine as a stimulator for plasminogen activationL C Petersen, P Handest, J Brender, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 1, 1984
Plasma and urine fibronectin concentration in kidney-transplanted patientsH O Eriksen, O Skjoldby, H Kjersem, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Diabetes and Its Complications|April 1, 1995
Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?E Boel, J Selmer, H J Flodgaard, et al.
Clinical Chemistry|August 1, 1990
Analytical evaluation of a sensitive enzyme immunoassay for determinations of creatine kinase isoenzyme MBP J Jørgensen, M Hørder, J Selmer, et al.
European Journal of Biochemistry|July 15, 1988
Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2S Thorsen, M Philips, J Selmer, et al.
Thrombosis and Haemostasis|October 28, 1987
Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasmaM Jørgensen, M Philips, S Thorsen, et al.
European Journal of Nuclear Medicine|January 1, 1991
Detection of deep venous thrombosis with indium 111-labelled monoclonal antibody against tissue plasminogen activatorN Tromholt, B Hesse, O Folkenborg, et al.
Journal of Immunoassay|January 1, 1988
Monoclonal antibodies against human angiotensinogen, their characterization and use in an angiotensinogen enzyme linked immunosorbent assayI Rubin, S Lykkegaard, A A Olsen, et al.
Thrombosis and Haemostasis|November 10, 1992
A specific immunologic assay for functional plasminogen activator inhibitor 1 in plasma--standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic diseaseM Philips, A G Juul, J Selmer, et al.
Thrombosis and Haemostasis|April 30, 1986
Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placentaM Philips, A G Juul, S Thorsen, et al.
Thrombosis and Haemostasis|April 7, 1987
A sensitive solid-phase immunosorbent assay for tissue-type plasminogen activator activity in plasma using trinitrobenzoylated poly-D-lysine as a stimulator for plasminogen activationL C Petersen, P Handest, J Brender, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 1, 1984
Plasma and urine fibronectin concentration in kidney-transplanted patientsH O Eriksen, O Skjoldby, H Kjersem, et al.
Pageof 3